Longevity has no shortage of lists telling you what to take. What it is short of is anyone who can say why any of it should work. Dr. Sandra Kaufmann built that part first, which is why I keep pointing physicians to her work.
She was a cell biologist before she was a physician, and went to medical school, in her words, because cells do not pay bills. Twenty-three years of clinical practice as a pediatric anesthesiologist followed. About ten years ago, hanging off a cliff as a rock climber, she decided she was done with what she calls the aging garbage and set out to understand why we age at all.
What she arrived at is that cells fail in seven categories, and that if you know which category a person is losing, you know what to give them.
How cells fail: the seven categories
- DNA alterations. Telomeres shorten and heterochromatin is lost, the structure that keeps the genetic code organized. When the DNA falls apart, the cell stops functioning correctly.
- Mitochondrial failure. Mitochondria supply the ATP a cell runs on, and they fail for six or seven distinct biochemical reasons with age. When energy drops, repair stops.
- Biochemical pathways. Kaufmann works from four: the sirtuins, AMPK as the metabolic switch, mTOR for growth and protein synthesis, and circadian rhythm as the clock governing repair cycles.
- Quality control and repair. Autophagy is how a cell recycles its own broken parts. Stop recycling and the debris accumulates on the factory floor.
- Immune function and inflammaging. The immune response becomes uncoordinated with age, worse at meeting new infections and stuck in a chronic inflammatory state.
- Individual cell requirements. Not every cell has the same needs. This is where senolytics and stem cell support sit.
- Waste management. Glycation, which is sugar damage to proteins. Lipofuscin, the metabolic waste that accumulates. And heavy metal load, iron in particular.
The Kaufmann Rating System
The part that makes this usable in a practice is the scoring. Kaufmann rates every agent, supplement or pharmaceutical, from 0 to 3 in each of the seven tenets, which gives every one of them a seven-digit number. Resveratrol, NAD+ and metformin all carry one. She calls the result a mathematical algorithm rather than a recommendation, and it is what lets her build a protocol around what a particular person is actually losing rather than around what is fashionable.
Her worked example is straightforward. Someone prediabetic collects agents in the waste management category. A family history of cancer points at DNA repair. Someone with nothing obvious gets an agent that scores in every category.
Where exosomes fit in a schedule
Asked what sits in the monthly to quarterly part of a schedule, Kaufmann said that in her view anyone over 40 should be getting exosome infusions. Her reasoning is coverage rather than potency. Because exosomes act as signaling messengers, they drop into almost every one of the seven tenets at once, which a friend of hers describes as carpet bombing.
That is her position, stated on our podcast, and it is worth being clear that it is hers. It is also worth saying what sits behind it. The rating system is her own non-clinical research rather than a consensus standard, and there is no trial establishing that exosome infusions change outcomes in healthy adults over 40. It is a reasoned position from someone who has read the literature closely, which is not the same as a settled one.
Matching the protocol to the person
Kaufmann is not arguing that aging is optional. Her argument is that its progression can be slowed, and the gap between how long we live and how well we live is the thing worth closing.
What I take from her work is the order of operations. Most longevity content starts with the agent and works backwards to a justification. She starts with which of the seven a person is losing and only then asks what to give. Run it that way and two patients with the same complaint end up on different protocols, which is the whole argument for assessing before prescribing.
The next time the room is in one place is the Winter Edition at the Omni Fort Lauderdale. The Regenerative Clinical Cadaver Lab runs Thursday, February 4, 2027, with limited seats, followed by two days of lectures on February 5 and 6, all CME-accredited. Registration is open:


